![]() | |
Names | |
---|---|
Other names Photochlor | |
Identifiers | |
3D model (JSmol) | |
Abbreviations | HPPH |
ChemSpider | |
PubChem CID | |
UNII | |
| |
| |
Properties | |
C39H48N4O4 | |
Molar mass | 636.837 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy. [1]
It is being developed under the brand name Photochlor.
A phase I/II clinical trial started in 1997 for esophageal cancer. [2]
A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011. [3]